Business Context and Reporting Period
Company: Inter Parfums, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001
Business Overview: A leading manufacturer and distributor of prestige and mass market fragrances, cosmetics, and personal care products. The company operates globally with significant exposure to European markets.
Key Financial Metrics
| Metric | 9 Months Ended Sep 30, 2001 | 9 Months Ended Sep 30, 2000 | 3 Months Ended Sep 30, 2001 |
|---|---|---|---|
| Net Sales | $84,931,066 | $72,385,779 | $27,628,127 |
| Gross Margin | $41,453,238 (48.8%) | $33,676,622 (46.5%) | $13,280,695 (48.1%) |
| Net Income | $5,894,977 | $4,565,090 | $1,922,321 |
| Diluted EPS | $0.30 | $0.23 | $0.10 |
| Cash & Equivalents | $29,272,364 | $22,398,695 (End of Period) | N/A |
| Working Capital | $67,288,190 | N/A | N/A |
| Long-Term Debt | $1,459,610 | $1,416,631 | N/A |
| Bank Loans (Current) | $6,240,251 | $2,542,286 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17% year-over-year for the nine-month period, driven by growth in both prestige and mass market lines. At comparable exchange rates, sales increased 22%.
- Profitability: Net income rose 29% to $5.9 million. Gross margins improved to 49% (9 months) and 48% (3 months) compared to 47% and 46% in the prior year, aided by a strong US dollar against the Euro and a higher mix of prestige products.
- Operating Expenses: Selling, General, and Administrative (SG&A) expenses increased to $30.6 million (36% of sales) from $25.4 million (35% of sales), reflecting increased advertising to support new product launches.
- Cash Flow: Net cash provided by operating activities turned positive at $0.1 million for the nine months ended September 30, 2001, compared to a use of $4.8 million in the prior year.
- Capital Structure: The company executed a 3-for-2 stock split in September 2001. Bank loans payable increased by approximately $3.7 million to fund operations and inventory buildup.
Guidance, Outlook, and Risks
- Full Year Guidance: Management forecasts full-year 2001 sales of approximately $111 million and net income of approximately $8.1 million.
- Product Pipeline: New launches include Celine fragrances (Q4 2001), Christian Lacroix (early 2002), and FUBU (January 2002). Mass market health and beauty aids (HBA) under the "Intimate" brand are performing well.
- Market Risks: Management notes potential impacts from cutbacks in discretionary consumer spending and declining traffic at duty-free stores. Currency fluctuations remain a key variable.
- Legal Contingency: The company is appealing a judgment in France regarding the "Ombre Rose" trademark. A $600,000 charge was previously taken. Management does not believe the litigation will have a further material adverse effect.
- Accounting Changes: The company adopted SFAS No. 133 (Derivatives) on January 1, 2001, resulting in a cumulative effect adjustment of $274,000 to accumulated other comprehensive income.
Investor Verification Checklist
- Inventory Levels: Verify the $5.6 million increase in inventory against the pace of new product launches and sales velocity to ensure no obsolescence risk.
- Foreign Exchange Exposure: Confirm the effectiveness of hedging strategies given the company's heavy reliance on European sales denominated in foreign currencies.
- Legal Resolution: Monitor the status of the "Ombre Rose" litigation appeal in France for any potential additional financial exposure beyond the accrued $600,000.
- Consumer Spending Trends: Assess the impact of the broader economic environment on luxury goods sales, particularly in the fourth quarter.
- Debt Utilization: Review the utilization of the $12 million domestic and $12 million international credit lines to ensure liquidity remains robust.